- Generic name
- Ticagrelor
- Strength
- 90 mg
- Dosage form
- Tablet
- Manufactured by
- Opsonin Pharma Limited
Brirel 90 Tablet
About Brirel 90 Tablet
Brirel 90 comes as a tablet with 90 mg of Ticagrelor, from Opsonin Pharma Limited. This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction.
There are 13 brands of Ticagrelor listed in Bangladesh. The lowest listed price is Belinta 60 mg Tablet at ৳ 35.00 per unit.
What is Brirel 90 Tablet?
Brirel 90 is a tablet from Opsonin Pharma Limited, with the generic name Ticagrelor. Brirel 90 is taken together with aspirin. Its active ingredient is Ticagrelor, which belongs to a group of medicines called anti-platelet drugs. Ask your doctor or pharmacist if you are unsure about it.
Uses of Brirel 90
This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction. It is prescribed whether the patient is managed with medicines alone or with procedures such as percutaneous coronary intervention or coronary artery bypass grafting. Brirel 90 is used in adults to help prevent atherothrombotic events after an acute coronary syndrome. Your doctor will decide if it is suitable for you.
How to use Brirel 90
Take Brirel 90 exactly as the doctor prescribes. Swallow the tablet with water. Brirel 90 is taken by mouth. It can be taken with or without food. If you miss a dose, ask the doctor or pharmacist what to do; the product information advises taking only the next scheduled tablet and not doubling up. Do not stop or change the medicine on your own, because stopping can raise the risk of heart attack, stent thrombosis and death.
Side effects of Brirel 90
Common side effects that have been reported with Ticagrelor include shortness of breath, bleeding, headache, cough, dizziness, nausea, diarrhoea, back pain, fatigue, chest pain, low blood pressure, high blood pressure and atrial fibrillation. The doctor can advise whether you need review or a change in treatment. Because it affects platelets, bleeding is a particular concern. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
It is not for people with moderate to severe liver problems or with allergies to the ingredients. Brirel 90 increases the risk of bleeding, so tell the doctor about any bleeding problem, peptic ulcer or past bleeding in the brain. It is not recommended in pregnancy, and it should not be used while breastfeeding unless the doctor decides the benefits outweigh the risks. Ask your doctor first if any of these apply to you.
Frequently asked questions
Why is Brirel 90 prescribed?
This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction. It is prescribed whether the patient is managed with medicines alone or with procedures such as percutaneous coronary intervention or coronary artery bypass grafting.
How is Brirel 90 used?
Take Brirel 90 exactly as the doctor prescribes. Swallow the tablet with water.
Can Brirel 90 cause side effects?
Common side effects that have been reported with Ticagrelor include shortness of breath, bleeding, headache, cough, dizziness, nausea, diarrhoea, back pain, fatigue, chest pain, low blood pressure, high blood pressure and atrial fibrillation. The doctor can advise whether you need review or a change in treatment.
Can I use Brirel 90 in pregnancy or while breastfeeding?
It is not for people with moderate to severe liver problems or with allergies to the ingredients. Brirel 90 increases the risk of bleeding, so tell the doctor about any bleeding problem, peptic ulcer or past bleeding in the brain.
Indications
Pharmacology
Dosage & Administration
A patient who misses a dose of Ticagrelor should take only one 90 mg tablet (the next dose) at its scheduled time. Patients treated with Clopidogrel can be directly switched to Ticagrelor if needed. Switching from prasugrel to ticagrelor has not been investigated.
Treatment is recommended for up to 12 months unless discontinuation of Ticagrelor is clinically indicated. Ticagrelor can be administered with or without food.
Interaction
CYP3A inducers: Avoid use with potent inducers of CYP3A (e.g., rifampin, dexamethasone, phenytoin,carbamazepine and phenobarbital).
Aspirin: Use of Ticagrelor with aspirin maintenance doses above 100 mg reduced the effectiveness ofTicagrelor.
Simvastatin, Lovastatin: Ticagrelor will result in higher serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4. Avoid simvastatin and lovastatin doses greater than 40 mg.
Digoxin: Because of inhibition of the P-glycoprotein transporter, monitor digoxin levels with initiation of or any change in ticagrelor therapy.
Other Concomitant Therapy: Ticagrelor can be administered with unfractionated or low-molecular-weight heparin, GPIIb/llla inhibitors, proton pump inhibitors, beta-blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers.
Contraindications
- Hypersensitivity to Ticagrelor or to any of the excipients
- Active pathological bleeding (peptic ulcer)
- History of intracranial haemorrhage
- Moderate to severe hepatic impairment
- Co-administration of Ticagrelor with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, nefazodone, ritonavir, and atazanavir)
Side Effects
Pregnancy & Lactation
Nursing mothers: Available pharmacodynamic/toxicological data in animals have shown excretion of Ticagrelor and its active metabolites in milk. A risk to newborns/infants cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from ticagrelor therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the women.
Precautions & Warnings
Concomitant Aspirin Maintenance Dose: Use of Ticagrelor with maintenance doses of aspirin above 100 mg decreased the effectiveness of Ticagrelor. Therefore, after the initial loading dose of aspirin (usually 325 mg), use Ticagrelor with a maintenance dose of aspirin of 75-100 mg.
Moderate Hepatic Impairment: Ticagrelor has not been studied in patients with moderate hepatic impairment.
Discontinuation of Ticagrelor: Discontinuation of Ticagrelor will increase the risk of myocardial infarction, stent thrombosis, and death.
Overdose Effects
Storage Conditions
Alternative brands of Ticagrelor
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.